1. Home
  2. NTZ vs SCLX Comparison

NTZ vs SCLX Comparison

Compare NTZ & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTZ
  • SCLX
  • Stock Information
  • Founded
  • NTZ 1959
  • SCLX 2011
  • Country
  • NTZ Italy
  • SCLX United States
  • Employees
  • NTZ N/A
  • SCLX N/A
  • Industry
  • NTZ Home Furnishings
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTZ Consumer Discretionary
  • SCLX Health Care
  • Exchange
  • NTZ Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • NTZ 37.2M
  • SCLX 35.7M
  • IPO Year
  • NTZ 1993
  • SCLX N/A
  • Fundamental
  • Price
  • NTZ $3.25
  • SCLX $16.46
  • Analyst Decision
  • NTZ
  • SCLX Buy
  • Analyst Count
  • NTZ 0
  • SCLX 2
  • Target Price
  • NTZ N/A
  • SCLX $245.00
  • AVG Volume (30 Days)
  • NTZ 1.8K
  • SCLX 255.7K
  • Earning Date
  • NTZ 01-01-0001
  • SCLX 08-13-2025
  • Dividend Yield
  • NTZ N/A
  • SCLX N/A
  • EPS Growth
  • NTZ N/A
  • SCLX N/A
  • EPS
  • NTZ N/A
  • SCLX N/A
  • Revenue
  • NTZ $337,653,480.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • NTZ N/A
  • SCLX $89.26
  • Revenue Next Year
  • NTZ N/A
  • SCLX $203.95
  • P/E Ratio
  • NTZ N/A
  • SCLX N/A
  • Revenue Growth
  • NTZ N/A
  • SCLX N/A
  • 52 Week Low
  • NTZ $2.15
  • SCLX $3.60
  • 52 Week High
  • NTZ $6.27
  • SCLX $39.90
  • Technical
  • Relative Strength Index (RSI)
  • NTZ 57.30
  • SCLX 47.62
  • Support Level
  • NTZ $2.70
  • SCLX $13.08
  • Resistance Level
  • NTZ $3.27
  • SCLX $14.74
  • Average True Range (ATR)
  • NTZ 0.16
  • SCLX 1.51
  • MACD
  • NTZ 0.03
  • SCLX -0.07
  • Stochastic Oscillator
  • NTZ 77.46
  • SCLX 55.24

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: